Boston Trust Walden’s Prestige Consumer Healthcare PBH Stock Holding History

Boston Trust Walden’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.8M	Sell	609,949 -33,391	-5%	-$1.72M	0.22%	155
2026 Q1	$38.1M	Sell	643,340 -70,432	-10%	-$4.57M	0.31%	119
2025 Q4	$44M	Sell	713,772 -72,314	-9%	-$4.43M	0.33%	119
2025 Q3	$49.1M	Sell	786,086 -14,080	-2%	-$980K	0.36%	114
2025 Q2	$63.9M	Sell	800,166 -19,116	-2%	-$1.6M	0.46%	77
2025 Q1	$70.4M	Sell	819,282 -12,345	-1%	-$1.01M	0.51%	68
2024 Q4	$64.9M	Buy	831,627 +252,089	+43%	+$19.6M	0.46%	70
2024 Q3	$41.8M	Buy	+579,538	New	+$41M	0.29%	138

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Trust Walden's PBH Position: Q2 2026 in Review

Boston Trust Walden reduced its Prestige Consumer Healthcare (PBH) stake by 5.2% in Q2 2026, selling an estimated $1.72M and leaving 609,949 shares worth $28.8M. The position accounts for 0.22% of the portfolio, ranked #155.

Boston Trust Walden first reported a position in PBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $70.4M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

Boston Trust Walden held 609,949 shares of Prestige Consumer Healthcare worth $28.8M as of Q2 2026.
Boston Trust Walden sold 33,391 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.72M.
Prestige Consumer Healthcare made up 0.22% of Boston Trust Walden's portfolio in Q2 2026, its #155 holding.
Boston Trust Walden first reported a position in Prestige Consumer Healthcare in Q3 2024 and has held it in 8 quarters since.
Boston Trust Walden's Prestige Consumer Healthcare position peaked at $70.4M in Q1 2025.
319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.